TXG ▼ -5.3% - 10x Genomics, Inc. $TXG QGEN - 10x Genomics Wins Patent Infringement Verdict Against Parse Biosciences 10x Genomics shares declined 5.3% despite winning a patent infringement verdict against competitor Parse Biosciences. While the legal victory could protect 10x's market position, investors may have focused on other factors not detailed in the headline, such as broader market conditions, earnings concerns, or guidance issues that outweighed the positive news from the patent ruling. 28-AUG-2026 02:39 PM ET